stella
beta
Nonmyeloablative Stem Cell Transplant in Children with Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor — Stella
Recruiting
Back to Sickle Cell Disease trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Canada
Alberta Children's Hospital, Calgary, Alberta
View full record on ClinicalTrials.gov